Asset Dedication LLC’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.9K | Sell |
333
-277
| -45% | -$26.5K | ﹤0.01% | 571 |
|
|
2025
Q4 | $58.6K | Sell |
610
-3,137
| -84% | -$305K | ﹤0.01% | 476 |
|
|
2025
Q3 | $357K | Sell |
3,747
-231
| -6% | -$21.2K | 0.02% | 252 |
|
|
2025
Q2 | $347K | Buy |
3,978
+2,802
| +238% | +$238K | 0.03% | 251 |
|
|
2025
Q1 | $106K | Sell |
1,176
-741
| -39% | -$66.3K | 0.01% | 364 |
|
|
2024
Q4 | $153K | Buy |
1,917
+313
| +20% | +$27.1K | 0.01% | 327 |
|
|
2024
Q3 | $144K | Sell |
1,604
-57
| -3% | -$4.79K | 0.01% | 369 |
|
|
2024
Q2 | $131K | Buy |
1,661
+40
| +2% | +$3.28K | 0.01% | 369 |
|
|
2024
Q1 | $140K | Sell |
1,621
-65
| -4% | -$5.55K | 0.01% | 337 |
|
|
2023
Q4 | $138K | Buy |
1,686
+147
| +10% | +$11.2K | 0.01% | 333 |
|
|
2023
Q3 | $120K | Sell |
1,539
-90
| -6% | -$7.53K | 0.01% | 343 |
|
|
2023
Q2 | $144K | Buy |
1,629
+90
| +6% | +$7.75K | 0.01% | 336 |
|
|
2023
Q1 | $124K | Sell |
1,539
-8
| -0.5% | -$652 | 0.01% | 342 |
|
|
2022
Q4 | $121K | Buy |
1,547
+198
| +15% | +$16K | 0.01% | 347 |
|
|
2022
Q3 | $108K | Hold |
1,349
| – | – | 0.01% | 332 |
|
|
2022
Q2 | $121K | Sell |
1,349
-215
| -14% | -$21.8K | 0.02% | 182 |
|
|
2022
Q1 | $174K | Sell |
1,564
-399
| -20% | -$42.2K | 0.02% | 306 |
|
|
2021
Q4 | $202K | Sell |
1,963
-40
| -2% | -$4.63K | 0.02% | 276 |
|
|
2021
Q3 | $249K | Buy |
2,003
+225
| +13% | +$29.1K | 0.03% | 246 |
|
|
2021
Q2 | $220K | Buy |
1,778
+35
| +2% | +$4.39K | 0.03% | 248 |
|
|
2021
Q1 | $206K | Sell |
1,743
-1,907
| -52% | -$224K | 0.05% | 214 |
|
|
2020
Q4 | $427K | Buy |
3,650
+3,527
| +2,867% | +$388K | 0.09% | 177 |
|
|
2020
Q3 | $13K | Buy |
123
+35
| +40% | +$3.52K | ﹤0.01% | 503 |
|
|
2020
Q2 | $8K | Hold |
88
| – | – | ﹤0.01% | 484 |
|
|
2020
Q1 | $8K | Sell |
88
-94
| -52% | -$10K | ﹤0.01% | 481 |
|
|
2019
Q4 | $21K | Buy |
182
+94
| +107% | +$10.3K | 0.01% | 395 |
|
|
2019
Q3 | $10K | Hold |
88
| – | – | ﹤0.01% | 446 |
|
|
2019
Q2 | $9K | Hold |
88
| – | – | ﹤0.01% | 437 |
|
|
2019
Q1 | $8K | Hold |
88
| – | – | ﹤0.01% | 471 |
|
|
2018
Q4 | $8K | Hold |
88
| – | – | ﹤0.01% | 448 |
|
|
2018
Q3 | $9K | Sell |
88
-43
| -33% | -$3.98K | ﹤0.01% | 456 |
|
|
2018
Q2 | $12K | Hold |
131
| – | – | ﹤0.01% | 424 |
|
|
2018
Q1 | $10K | Sell |
131
-177
| -57% | -$14.6K | 0.01% | 375 |
|
|
2017
Q4 | $24K | Buy |
308
+265
| +616% | +$21.2K | 0.01% | 288 |
|
|
2017
Q3 | $3K | Hold |
43
| – | – | ﹤0.01% | 344 |
|
|
2017
Q2 | $4K | Sell |
43
-18
| -30% | -$1.52K | ﹤0.01% | 348 |
|
|
2017
Q1 | $4K | Hold |
61
| – | – | ﹤0.01% | 345 |
|
|
2016
Q4 | $4K | Sell |
61
-100
| -62% | -$7.86K | ﹤0.01% | 347 |
|
|
2016
Q3 | $15K | Hold |
161
| – | – | 0.01% | 272 |
|
|
2016
Q2 | $15K | Buy |
161
+37
| +30% | +$2.99K | 0.01% | 252 |
|
|
2016
Q1 | $9K | Sell |
124
-1,449
| -92% | -$109K | 0.01% | 313 |
|
|
2015
Q4 | $121K | Buy |
+1,573
| New | +$118K | 0.08% | 166 |
|
Other funds holding MDT
VCM
VPM
Asset Dedication LLC's MDT Position: Q1 2026 in Review
Asset Dedication LLC reduced its Medtronic (MDT) stake by 45% in Q1 2026, selling an estimated $26.5K and leaving 333 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #571.
Asset Dedication LLC first reported a position in MDT in Q4 2015 and has held it in 42 quarters since. The position peaked at $427K in Q4 2020. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Asset Dedication LLC held 333 shares of Medtronic worth $28.9K as of Q1 2026.
- Asset Dedication LLC sold 277 Medtronic shares in Q1 2026, an estimated $26.5K.
- Medtronic made up ﹤0.01% of Asset Dedication LLC's portfolio in Q1 2026, its #571 holding.
- Asset Dedication LLC first reported a position in Medtronic in Q4 2015 and has held it in 42 quarters since.
- Asset Dedication LLC's Medtronic position peaked at $427K in Q4 2020.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Asset Dedication LLC's 13F filing for Q1 2026, filed 29 May 2026.